Electric field device tested to fight recurrent brain tumors
NCT ID NCT03450850
Summary
This study tested a wearable medical device called NOVOTTF-200A in adults with recurrent grade 3 astrocytoma, a type of brain cancer that had worsened after initial treatment. The device uses low-intensity electric fields applied to the scalp, aiming to slow or stop cancer cell growth. The main goal was to see how many patients showed no further cancer progression after six months of using the device.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTROCYTOMA, GRADE III are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of California, Irvine
Orange, California, 92868, United States
Conditions
Explore the condition pages connected to this study.